APO Research
Talk to an analyst

APO RESEARCH · REPORT

Insulin Like Growth Factor I

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Insulin Like Growth Factor I Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025177 pages

Choose your research edition.

Industry ResearchInsulin Like Growth Factor I Industry Research Report 2026105 pages · $2,950 USDIndustry Growth & TrendsGlobal Insulin Like Growth Factor I Industry Growth and Trends Forecast to 203278 pages · $3,450 USDMarket StructureGlobal Insulin Like Growth Factor I Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032177 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Insulin Like Growth Factor I Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Insulin Like Growth Factor I Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Insulin Like Growth Factor I market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Insulin Like Growth Factor I is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Insulin Like Growth Factor I is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Insulin Like Growth Factor I is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Insulin Like Growth Factor I is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Insulin Like Growth Factor I include Regulaxis SAS, MedImmune LLC, Genervon Biopharmaceuticals LLC and Boehringer Ingelheim GmbH, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Insulin Like Growth Factor I market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Insulin Like Growth Factor I and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Insulin Like Growth Factor I sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Insulin Like Growth Factor I market size, projected growth trends, production technologies, key applications, and end-use industries.

Insulin Like Growth Factor I Segment by Company

Regulaxis SAS

MedImmune LLC

Genervon Biopharmaceuticals LLC

Boehringer Ingelheim GmbH

Insulin Like Growth Factor I Segment by Type

CIGB-845

Dusigitumab

M-630

M-610.27

GM-6

Others

Insulin Like Growth Factor I Segment by Application

Breast Cancer

Muscular Dystrophy

Huntington Disease

Alzheimer's Disease

Others

Insulin Like Growth Factor I Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Insulin Like Growth Factor I market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Insulin Like Growth Factor I and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Insulin Like Growth Factor I.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Insulin Like Growth Factor I market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Insulin Like Growth Factor I manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Insulin Like Growth Factor I in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Insulin Like Growth Factor I in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Insulin Like Growth Factor I Industry Trends Table 2. Insulin Like Growth Factor I Industry Drivers Table 3. Insulin Like Growth Factor I Industry Opportunities and Challenges Table 4. Insulin Like Growth Factor I Industry Restraints Table 5. Global Insulin Like Growth Factor I Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Insulin Like Growth Factor I Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Insulin Like Growth Factor I Sales by Manufacturers (W Units) & (2021-2026) Table 8. Global Insulin Like Growth Factor I Sales Market Share by Manufacturers Table 9. Global Insulin Like Growth Factor I Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Insulin Like Growth Factor I Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Insulin Like Growth Factor I Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Insulin Like Growth Factor I Manufacturers, Product Type & Application Table 13. Global Insulin Like Growth Factor I Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Insulin Like Growth Factor I by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of CIGB-845 Table 17. Major Manufacturers of Dusigitumab Table 18. Major Manufacturers of M-630 Table 19. Major Manufacturers of M-610.27 Table 20. Major Manufacturers of GM-6 Table 21. Major Manufacturers of Others Table 22. Global Insulin Like Growth Factor I Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 23. Global Insulin Like Growth Factor I Sales by Type (2021-2026) & (W Units) Table 24. Global Insulin Like Growth Factor I Sales by Type (2027-2032) & (W Units) Table 25. Global Insulin Like Growth Factor I Sales Market Share by Type (2021-2026) Table 26. Global Insulin Like Growth Factor I Sales Market Share by Type (2027-2032) Table 27. Global Insulin Like Growth Factor I Revenue by Type 2021 VS 2025 VS 2032 (W Units) Table 28. Global Insulin Like Growth Factor I Revenue by Type (2021-2026) & (W Units) Table 29. Global Insulin Like Growth Factor I Revenue by Type (2027-2032) & (W Units) Table 30. Global Insulin Like Growth Factor I Revenue Market Share by Type (2021-2026) Table 31. Global Insulin Like Growth Factor I Revenue Market Share by Type (2027-2032) Table 32. Major Manufacturers of Breast Cancer Table 33. Major Manufacturers of Muscular Dystrophy Table 34. Major Manufacturers of Huntington Disease Table 35. Major Manufacturers of Alzheimer's Disease Table 36. Major Manufacturers of Others Table 37. Global Insulin Like Growth Factor I Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 38. Global Insulin Like Growth Factor I Sales by Application (2021-2026) & (W Units) Table 39. Global Insulin Like Growth Factor I Sales by Application (2027-2032) & (W Units) Table 40. Global Insulin Like Growth Factor I Sales Market Share by Application (2021-2026) Table 41. Global Insulin Like Growth Factor I Sales Market Share by Application (2027-2032) Table 42. Global Insulin Like Growth Factor I Revenue by Application 2021 VS 2025 VS 2032 (W Units) Table 43. Global Insulin Like Growth Factor I Revenue by Application (2021-2026) & (W Units) Table 44. Global Insulin Like Growth Factor I Revenue by Application (2027-2032) & (W Units) Table 45. Global Insulin Like Growth Factor I Revenue Market Share by Application (2021-2026) Table 46. Global Insulin Like Growth Factor I Revenue Market Share by Application (2027-2032) Table 47. Global Insulin Like Growth Factor I Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 48. Global Insulin Like Growth Factor I Sales by Region (2021-2026) & (W Units) Table 49. Global Insulin Like Growth Factor I Sales Market Share by Region (2021-2026) Table 50. Global Insulin Like Growth Factor I Sales Forecasted by Region (2027-2032) & (W Units) Table 51. Global Insulin Like Growth Factor I Sales Forecasted Market Share by Region (2027-2032) Table 52. North America Insulin Like Growth Factor I Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 53. North America Insulin Like Growth Factor I Sales by Country (2021-2026) & (W Units) Table 54. North America Insulin Like Growth Factor I Sales by Country (2027-2032) & (W Units) Table 55. Europe Insulin Like Growth Factor I Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 56. Europe Insulin Like Growth Factor I Sales by Country (2021-2026) & (W Units) Table 57. Europe Insulin Like Growth Factor I Sales by Country (2027-2032) & (W Units) Table 58. Asia Pacific Insulin Like Growth Factor I Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 59. Asia Pacific Insulin Like Growth Factor I Sales by Country (2021-2026) & (W Units) Table 60. Asia Pacific Insulin Like Growth Factor I Sales by Country (2027-2032) & (W Units) Table 61. South America, Middle East and Africa Insulin Like Growth Factor I Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 62. South America, Middle East and Africa Insulin Like Growth Factor I Sales by Country (2021-2026) & (W Units) Table 63. South America, Middle East and Africa Insulin Like Growth Factor I Sales by Country (2027-2032) & (W Units) Table 64. Global Insulin Like Growth Factor I Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 65. Global Insulin Like Growth Factor I Revenue by Region (2021-2026) & (US$ Million) Table 66. Global Insulin Like Growth Factor I Revenue by Region (2027-2032) & (US$ Million) Table 67. Global Insulin Like Growth Factor I Revenue Market Share by Region (2021-2026) Table 68. Global Insulin Like Growth Factor I Revenue Market Share by Region (2027-2032) Table 69. Regulaxis SAS Company Information Table 70. Regulaxis SAS Business Overview Table 71. Regulaxis SAS Insulin Like Growth Factor I Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Regulaxis SAS Insulin Like Growth Factor I Product Portfolio Table 73. Regulaxis SAS Recent Development Table 74. MedImmune LLC Company Information Table 75. MedImmune LLC Business Overview Table 76. MedImmune LLC Insulin Like Growth Factor I Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. MedImmune LLC Insulin Like Growth Factor I Product Portfolio Table 78. MedImmune LLC Recent Development Table 79. Genervon Biopharmaceuticals LLC Company Information Table 80. Genervon Biopharmaceuticals LLC Business Overview Table 81. Genervon Biopharmaceuticals LLC Insulin Like Growth Factor I Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Genervon Biopharmaceuticals LLC Insulin Like Growth Factor I Product Portfolio Table 83. Genervon Biopharmaceuticals LLC Recent Development Table 84. Boehringer Ingelheim GmbH Company Information Table 85. Boehringer Ingelheim GmbH Business Overview Table 86. Boehringer Ingelheim GmbH Insulin Like Growth Factor I Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Boehringer Ingelheim GmbH Insulin Like Growth Factor I Product Portfolio Table 88. Boehringer Ingelheim GmbH Recent Development Table 89. Key Raw Materials Table 90. Raw Materials Key Suppliers Table 91. Insulin Like Growth Factor I Distributors List Table 92. Insulin Like Growth Factor I Customers List Table 93. Research Programs/Design for This Report Table 94. Authors List of This Report Table 95. Secondary Sources Table 96. Primary Sources List of Figures Figure 1. Insulin Like Growth Factor I Product Image Figure 2. Global Insulin Like Growth Factor I Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Insulin Like Growth Factor I Market Size (2021-2032) & (US$ Million) Figure 4. Global Insulin Like Growth Factor I Sales (2021-2032) & (W Units) Figure 5. Global Insulin Like Growth Factor I Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Insulin Like Growth Factor I Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. CIGB-845 Image Figure 9. Dusigitumab Image Figure 10. M-630 Image Figure 11. M-610.27 Image Figure 12. GM-6 Image Figure 13. Others Image Figure 14. Global Insulin Like Growth Factor I Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 15. Global Insulin Like Growth Factor I Sales Market Share 2021 VS 2025 VS 2032 Figure 16. Global Insulin Like Growth Factor I Sales Market Share by Type (2021-2032) Figure 17. Global Insulin Like Growth Factor I Revenue by Type (2021 VS 2025 VS 2032) & (W Units) Figure 18. Global Insulin Like Growth Factor I Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Insulin Like Growth Factor I Revenue Market Share by Type (2021-2032) Figure 20. Breast Cancer Image Figure 21. Muscular Dystrophy Image Figure 22. Huntington Disease Image Figure 23. Alzheimer's Disease Image Figure 24. Others Image Figure 25. Global Insulin Like Growth Factor I Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 26. Global Insulin Like Growth Factor I Sales Market Share 2021 VS 2025 VS 2032 Figure 27. Global Insulin Like Growth Factor I Sales Market Share by Application (2021-2032) Figure 28. Global Insulin Like Growth Factor I Revenue by Application (2021 VS 2025 VS 2032) & (W Units) Figure 29. Global Insulin Like Growth Factor I Revenue Market Share 2021 VS 2025 VS 2032 Figure 30. Global Insulin Like Growth Factor I Revenue Market Share by Application (2021-2032) Figure 31. North America Insulin Like Growth Factor I Sales and Growth Rate (2021-2032) & (W Units) Figure 32. North America Insulin Like Growth Factor I Sales Market Share by Country (2021-2032) Figure 33. U.S. Insulin Like Growth Factor I Sales and Growth Rate (2021-2032) & (W Units) Figure 34. Canada Insulin Like Growth Factor I Sales and Growth Rate (2021-2032) & (W Units) Figure 35. Mexico Insulin Like Growth Factor I Sales and Growth Rate (2021-2032) & (W Units) Figure 36. Europe Insulin Like Growth Factor I Sales and Growth Rate (2021-2032) & (W Units) Figure 37. Europe Insulin Like Growth Factor I Sales Market Share by Country (2021-2032) Figure 38. Germany Insulin Like Growth Factor I Sales and Growth Rate (2021-2032) & (W Units) Figure 39. France Insulin Like Growth Factor I Sales and Growth Rate (2021-2032) & (W Units) Figure 40. U.K. Insulin Like Growth Factor I Sales and Growth Rate (2021-2032) & (W Units) Figure 41. Italy Insulin Like Growth Factor I Sales and Growth Rate (2021-2032) & (W Units) Figure 42. Netherlands Insulin Like Growth Factor I Sales and Growth Rate (2021-2032) & (W Units) Figure 43. Asia Pacific Insulin Like Growth Factor I Sales and Growth Rate (2021-2032) & (W Units) Figure 44. Asia Pacific Insulin Like Growth Factor I Sales Market Share by Country (2021-2032) Figure 45. China Insulin Like Growth Factor I Sales and Growth Rate (2021-2032) & (W Units) Figure 46. Japan Insulin Like Growth Factor I Sales and Growth Rate (2021-2032) & (W Units) Figure 47. South Korea Insulin Like Growth Factor I Sales and Growth Rate (2021-2032) & (W Units) Figure 48. Southeast Asia Insulin Like Growth Factor I Sales and Growth Rate (2021-2032) & (W Units) Figure 49. India Insulin Like Growth Factor I Sales and Growth Rate (2021-2032) & (W Units) Figure 50. Australia Insulin Like Growth Factor I Sales and Growth Rate (2021-2032) & (W Units) Figure 51. South America, Middle East and Africa Insulin Like Growth Factor I Sales and Growth Rate (2021-2032) & (W Units) Figure 52. South America, Middle East and Africa Insulin Like Growth Factor I Sales Market Share by Country (2021-2032) Figure 53. Brazil Insulin Like Growth Factor I Sales and Growth Rate (2021-2032) & (W Units) Figure 54. South Africa Insulin Like Growth Factor I Sales and Growth Rate (2021-2032) & (W Units) Figure 55. Saudi Arabia Insulin Like Growth Factor I Sales and Growth Rate (2021-2032) & (W Units) Figure 56. Turkey Insulin Like Growth Factor I Sales and Growth Rate (2021-2032) & (W Units) Figure 57. Argentina Insulin Like Growth Factor I Sales and Growth Rate (2021-2032) & (W Units) Figure 58. UAE Insulin Like Growth Factor I Sales and Growth Rate (2021-2032) & (W Units) Figure 59. Egypt Insulin Like Growth Factor I Sales and Growth Rate (2021-2032) & (W Units) Figure 60. Chile Insulin Like Growth Factor I Sales and Growth Rate (2021-2032) & (W Units) Figure 61. Global Insulin Like Growth Factor I Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Global Insulin Like Growth Factor I Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 63. North America Insulin Like Growth Factor I Revenue (2021-2032) & (US$ Million) Figure 64. North America Insulin Like Growth Factor I Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Europe Insulin Like Growth Factor I Revenue (2021-2032) & (US$ Million) Figure 66. Europe Insulin Like Growth Factor I Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Asia-Pacific Insulin Like Growth Factor I Revenue (2021-2032) & (US$ Million) Figure 68. Asia-Pacific Insulin Like Growth Factor I Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. South America, Middle East and Africa Insulin Like Growth Factor I Revenue (2021-2032) & (US$ Million) Figure 70. South America, Middle East and Africa Insulin Like Growth Factor I Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 71. Insulin Like Growth Factor I Value Chain Figure 72. Manufacturing Cost Structure Figure 73. Insulin Like Growth Factor I Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Years Considered Figure 77. Research Process Figure 78. Key Executives Interviewed

Scope & coverage.

Types
  • CIGB-845
  • Dusigitumab
  • M-630
  • M-610.27
  • GM-6
  • Others
Applications
  • Breast Cancer
  • Muscular Dystrophy
  • Huntington Disease
  • Alzheimer's Disease
  • Others
Companies covered
  • Regulaxis SAS
  • MedImmune LLC
  • Genervon Biopharmaceuticals LLC
  • Boehringer Ingelheim GmbH

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Insulin Like Growth Factor I Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Insulin Like Growth Factor I Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Insulin Like Growth Factor I Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Insulin Like Growth Factor I Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Insulin Like Growth Factor I Market Dynamics
  1. 2.1 Insulin Like Growth Factor I Industry Trends
  2. 2.2 Insulin Like Growth Factor I Industry Drivers
  3. 2.3 Insulin Like Growth Factor I Industry Opportunities and Challenges
  4. 2.4 Insulin Like Growth Factor I Industry Restraints
3 Insulin Like Growth Factor I Market by Manufacturers
  1. 3.1 Global Insulin Like Growth Factor I Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Insulin Like Growth Factor I Sales by Manufacturers (2021-2026)
  3. 3.3 Global Insulin Like Growth Factor I Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Insulin Like Growth Factor I Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Insulin Like Growth Factor I Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Insulin Like Growth Factor I Manufacturers, Product Type & Application
  7. 3.7 Global Insulin Like Growth Factor I Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Insulin Like Growth Factor I Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Insulin Like Growth Factor I Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Insulin Like Growth Factor I Tier 1, Tier 2, and Tier 3
4 Insulin Like Growth Factor I Market by Type
  1. 4.1 Insulin Like Growth Factor I Type Introduction
  2. 4.1.1 CIGB-845
  3. 4.1.2 Dusigitumab
  4. 4.1.3 M-630
  5. 4.1.4 M-610.27
  6. 4.1.5 GM-6
  7. 4.1.6 Others
  8. 4.2 Global Insulin Like Growth Factor I Sales by Type
  9. 4.2.1 Global Insulin Like Growth Factor I Sales by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Insulin Like Growth Factor I Sales by Type (2021-2032)
  11. 4.2.3 Global Insulin Like Growth Factor I Sales Market Share by Type (2021-2032)
  12. 4.3 Global Insulin Like Growth Factor I Revenue by Type
  13. 4.3.1 Global Insulin Like Growth Factor I Revenue by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Insulin Like Growth Factor I Revenue by Type (2021-2032)
  15. 4.3.3 Global Insulin Like Growth Factor I Revenue Market Share by Type (2021-2032)
5 Insulin Like Growth Factor I Market by Application
  1. 5.1 Insulin Like Growth Factor I Application Introduction
  2. 5.1.1 Breast Cancer
  3. 5.1.2 Muscular Dystrophy
  4. 5.1.3 Huntington Disease
  5. 5.1.4 Alzheimer's Disease
  6. 5.1.5 Others
  7. 5.2 Global Insulin Like Growth Factor I Sales by Application
  8. 5.2.1 Global Insulin Like Growth Factor I Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Insulin Like Growth Factor I Sales by Application (2021-2032)
  10. 5.2.3 Global Insulin Like Growth Factor I Sales Market Share by Application (2021-2032)
  11. 5.3 Global Insulin Like Growth Factor I Revenue by Application
  12. 5.3.1 Global Insulin Like Growth Factor I Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Insulin Like Growth Factor I Revenue by Application (2021-2032)
  14. 5.3.3 Global Insulin Like Growth Factor I Revenue Market Share by Application (2021-2032)
6 Global Insulin Like Growth Factor I Sales by Region
  1. 6.1 Global Insulin Like Growth Factor I Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Insulin Like Growth Factor I Sales by Region (2021-2032)
  3. 6.2.1 Global Insulin Like Growth Factor I Sales by Region (2021-2026)
  4. 6.2.2 Global Insulin Like Growth Factor I Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Insulin Like Growth Factor I Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Insulin Like Growth Factor I Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Insulin Like Growth Factor I Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Insulin Like Growth Factor I Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Insulin Like Growth Factor I Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Insulin Like Growth Factor I Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Insulin Like Growth Factor I Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Insulin Like Growth Factor I Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Insulin Like Growth Factor I Revenue by Region
  1. 7.1 Global Insulin Like Growth Factor I Revenue by Region
  2. 7.1.1 Global Insulin Like Growth Factor I Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Insulin Like Growth Factor I Revenue by Region (2021-2026)
  4. 7.1.3 Global Insulin Like Growth Factor I Revenue by Region (2027-2032)
  5. 7.1.4 Global Insulin Like Growth Factor I Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Insulin Like Growth Factor I Revenue (2021-2032)
  8. 7.2.2 North America Insulin Like Growth Factor I Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Insulin Like Growth Factor I Revenue (2021-2032)
  11. 7.3.2 Europe Insulin Like Growth Factor I Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Insulin Like Growth Factor I Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Insulin Like Growth Factor I Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Insulin Like Growth Factor I Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Insulin Like Growth Factor I Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Regulaxis SAS
  2. 8.1.1 Regulaxis SAS Company Information
  3. 8.1.2 Regulaxis SAS Business Overview
  4. 8.1.3 Regulaxis SAS Insulin Like Growth Factor I Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Regulaxis SAS Insulin Like Growth Factor I Product Portfolio
  6. 8.1.5 Regulaxis SAS Recent Developments
  7. 8.2 MedImmune LLC
  8. 8.2.1 MedImmune LLC Company Information
  9. 8.2.2 MedImmune LLC Business Overview
  10. 8.2.3 MedImmune LLC Insulin Like Growth Factor I Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 MedImmune LLC Insulin Like Growth Factor I Product Portfolio
  12. 8.2.5 MedImmune LLC Recent Developments
  13. 8.3 Genervon Biopharmaceuticals LLC
  14. 8.3.1 Genervon Biopharmaceuticals LLC Company Information
  15. 8.3.2 Genervon Biopharmaceuticals LLC Business Overview
  16. 8.3.3 Genervon Biopharmaceuticals LLC Insulin Like Growth Factor I Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Genervon Biopharmaceuticals LLC Insulin Like Growth Factor I Product Portfolio
  18. 8.3.5 Genervon Biopharmaceuticals LLC Recent Developments
  19. 8.4 Boehringer Ingelheim GmbH
  20. 8.4.1 Boehringer Ingelheim GmbH Company Information
  21. 8.4.2 Boehringer Ingelheim GmbH Business Overview
  22. 8.4.3 Boehringer Ingelheim GmbH Insulin Like Growth Factor I Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Boehringer Ingelheim GmbH Insulin Like Growth Factor I Product Portfolio
  24. 8.4.5 Boehringer Ingelheim GmbH Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Insulin Like Growth Factor I Value Chain Analysis
  2. 9.1.1 Insulin Like Growth Factor I Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Insulin Like Growth Factor I Production Mode & Process
  6. 9.2 Insulin Like Growth Factor I Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Insulin Like Growth Factor I Distributors
  9. 9.2.3 Insulin Like Growth Factor I Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst